SNZZF.US Senzime AB (publ)

Healthcare Health Care Equipment & Supplies USA Stocks
0.2946 USD
Close of Nov 3, 2026
0.2352 0.6175
Market cap
USD 46.3M
P/E
-
P/B
1.46x
ROE
-28.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SNZZF.US undervalued?

Graham number

The Graham number of Senzime AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Senzime AB (publ) fundamental analysis

No fundamental analysis for Senzime AB (publ) yet.

Senzime AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Senzime AB (publ)

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue's opposition to carrying an alternating electri…

Full company profile